These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Comparison of hybrid (68)Ga-PSMA PET/MRI and (68)Ga-PSMA PET/CT in the evaluation of lymph node and bone metastases of prostate cancer. Freitag MT; Radtke JP; Hadaschik BA; Kopp-Schneider A; Eder M; Kopka K; Haberkorn U; Roethke M; Schlemmer HP; Afshar-Oromieh A Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):70-83. PubMed ID: 26508290 [TBL] [Abstract][Full Text] [Related]
7. Reproducibility and Repeatability of Semiquantitative Vargas HA; Kramer GM; Scott AM; Weickhardt A; Meier AA; Parada N; Beattie BJ; Humm JL; Staton KD; Zanzonico PB; Lyashchenko SK; Lewis JS; Yaqub M; Sosa RE; van den Eertwegh AJ; Davis ID; Ackermann U; Pathmaraj K; Schuit RC; Windhorst AD; Chua S; Weber WA; Larson SM; Scher HI; Lammertsma AA; Hoekstra OS; Morris MJ J Nucl Med; 2018 Oct; 59(10):1516-1523. PubMed ID: 29626121 [No Abstract] [Full Text] [Related]
9. Repeatability of Quantitative 18F-Fluoromethylcholine PET/CT Studies in Prostate Cancer. Oprea-Lager DE; Kramer G; van de Ven PM; van den Eertwegh AJ; van Moorselaar RJ; Schober P; Hoekstra OS; Lammertsma AA; Boellaard R J Nucl Med; 2016 May; 57(5):721-7. PubMed ID: 26697964 [TBL] [Abstract][Full Text] [Related]
10. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
11. SUVs Are Adequate Measures of Lesional Bodar YJL; Koene BPF; Jansen BHE; Cysouw MCF; Meijer D; Hendrikse NH; Vis AN; Boellaard R; Oprea-Lager DE J Nucl Med; 2021 Sep; 62(9):1264-1269. PubMed ID: 33509971 [TBL] [Abstract][Full Text] [Related]
12. Prospective Comparison of PET Imaging with PSMA-Targeted Rowe SP; Li X; Trock BJ; Werner RA; Frey S; DiGianvittorio M; Bleiler JK; Reyes DK; Abdallah R; Pienta KJ; Gorin MA; Pomper MG J Nucl Med; 2020 Feb; 61(2):183-188. PubMed ID: 31451492 [TBL] [Abstract][Full Text] [Related]
13. 68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patients. Schmidkonz C; Cordes M; Goetz TI; Prante O; Kuwert T; Ritt P; Uder M; Wullich B; Goebell P; Bäuerle T Ann Nucl Med; 2019 Oct; 33(10):766-775. PubMed ID: 31338731 [TBL] [Abstract][Full Text] [Related]
14. Initial Experience with Volumetric Schmuck S; von Klot CA; Henkenberens C; Sohns JM; Christiansen H; Wester HJ; Ross TL; Bengel FM; Derlin T J Nucl Med; 2017 Dec; 58(12):1962-1968. PubMed ID: 28522740 [TBL] [Abstract][Full Text] [Related]
15. Changing Threshold-Based Segmentation Has No Relevant Impact on Semi-Quantification in the Context of Structured Reporting for PSMA-PET/CT. Mihatsch PW; Beissert M; Pomper MG; Bley TA; Seitz AK; Kübler H; Buck AK; Rowe SP; Serfling SE; Hartrampf PE; Werner RA Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053434 [TBL] [Abstract][Full Text] [Related]
16. Prospective inter- and intra-tracer repeatability analysis of radiomics features in [ Kendrick J; Francis RJ; Hassan GM; Rowshanfarzad P; Ong JSL; Jeraj R; Barry N; Hagan T; Ebert MA Br J Radiol; 2023 Dec; 96(1152):20221178. PubMed ID: 37751168 [TBL] [Abstract][Full Text] [Related]
17. qPSMA: Semiautomatic Software for Whole-Body Tumor Burden Assessment in Prostate Cancer Using Gafita A; Bieth M; Krönke M; Tetteh G; Navarro F; Wang H; Günther E; Menze B; Weber WA; Eiber M J Nucl Med; 2019 Sep; 60(9):1277-1283. PubMed ID: 30850484 [TBL] [Abstract][Full Text] [Related]